LBL, Even if the JT story is accurate, it may have simply been bluster on his part (maybe said in the process of rejecting an actual bid.) I would expect that any BO offers in the future will be carefully considered in the wake of the Corona Virus. The silver lining from the CV might be that some BP clinical trials have been "spoiled" and some that were planned may now be pushed back a while. This will result in some BP having a hole in their sales projections. Indeed, this situation could result in some additional competition for AMRN should takeover discussions heat up. Right now I'd be happy with most any deal that JT and the BOD would approve...even if done at one half the $100.
LBL - I hope you are right. I would be ok with GIA if the PPS increases substantially short-mid term, so I could sell as needed to pay for kids' school without missing out too much on the price increase. I do not have the luxury of waiting 3 years to hit a nice price target that could be reached in 3 months with a BO, which is the only reason I am in favor of a BO.
LBL... Appreciate your view and optimism. We need more of that around here. I continue to hold the belief that Amarin’s best days are soon ahead. Peace to all!